δ-Catenin Promotes Bevacizumab-Induced Glioma Invasion

Volume: 18, Issue: 4, Pages: 812 - 822
Published: Apr 1, 2019
Abstract
The combination of bevacizumab with temozolomide and radiotherapy was shown to prolong progression-free survival in newly diagnosed patients with glioblastoma, and this emphasizes the potential of bevacizumab as a glioma treatment. However, although bevacizumab effectively inhibits angiogenesis, it has also been reported to induce invasive proliferation. This study examined gene expression in glioma cells to investigate the mechanisms of...
Paper Details
Title
δ-Catenin Promotes Bevacizumab-Induced Glioma Invasion
Published Date
Apr 1, 2019
Volume
18
Issue
4
Pages
812 - 822
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.